Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of metastatic non-small cell bronchogenic carcinoma.

× No keyword cloud information.

13 in total

1. Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.

Authors: W K Lam; S Y So; M Ip; D Y Yu
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

Review 2. Chemotherapy of advanced non-small cell lung cancer. A review.

Authors: B J Takasugi; T P Miller
Journal: Invest New Drugs Date: 1984 Impact factor: 3.850

3. High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.

Authors: D R Gandara; E A Perez; H Wold; V Caggiano; M Malec; D K Ahn; F Meyers; R W Carlson
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

4. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.

Authors: W K Lam; S Y So; T M Kung; M K Sham; M Ip
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 5. Lung cancer--current concepts and controversies.

Authors: S B Pett; J A Wernly; B F Akl
Journal: West J Med Date: 1986-07

6. The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines.

Authors: J R Jett; N Saijo; W S Hong; Y Sasaki; H Takahashi; H Nakano; K Nakagawa; M Sakurai; K Suemasu; M Tesada
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

Review 7. Cisplatin: a review of clinical applications and renal toxicity.

Authors: D T Sleijfer; S Meijer; N H Mulder
Journal: Pharm Weekbl Sci Date: 1985-12-13

8. Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.

Authors: R Stuart-Harris; R M Fox; D Raghavan; A S Coates; D Hedley; J A Levi; R L Woods; M H Tattersall
Journal: Thorax Date: 1985-05 Impact factor: 9.139

9. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.

Authors: N J DiBella; R Berris; D Garfield; K Fink; J Speer; A Sakamoto
Journal: Invest New Drugs Date: 1984 Impact factor: 3.850

10. Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.

Authors: S K Williamson; J J Crowley; R B Livingston; T J Panella; J W Goodwin
Journal: Invest New Drugs Date: 1995 Impact factor: 3.850